Is metronidazole 0.75% gel effective in the treatment of seborrhoeic dermatitis? A double-blind, placebo controlled study

European Journal of Dermatology

Volumn 17, Issue 4, 2007, Pages 313-316

  Ozcan, Hamdi ^a   Seyhan, Muammer ^a   Yologlu, Saim ^a  

^a INONU UNIVERSITY   (Turkey)

Author keywords

Metronidazole; Seborrheic dermatitis

Indexed keywords

METRONIDAZOLE;

ADOLESCENT; ADULT; ARTICLE; ASSAULT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; ERYTHEMA; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PAPULE; PATIENT SATISFACTION; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SEBORRHEIC DERMATITIS; TREATMENT DURATION;

ADMINISTRATION, TOPICAL; ADULT; ANTI-INFECTIVE AGENTS; DERMATITIS, SEBORRHEIC; DOUBLE-BLIND METHOD; FEMALE; GELS; HUMANS; MALE; METRONIDAZOLE;

EID: 34447310578     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: 10.1684/ejd.2007.0206     Document Type: Article

References (24)

1. Gupta AK, Bluhm R, Barlow JO, Fleischer Jr. AB, Feldman SR. Prescribing practices for seborrheic dermatitis vary with the physician's specialty: implications for clinical practice. J Dermatolog Treat 2004; 15: 208-13.
2. Koca R, Altinyazar HC, Esturk E. Is topical metronidazole effective in seborrheic dermatitis? A double-blind study. Int J Dermatol 2003; 42: 632-5.
3. Fritsch PO, Reider N. Other eczematous eruptions. In: Bolognia JL, Jorizzo J, Rapini RP, et al., eds. Dermatology. Edinburgh: Mosby, 2004: 215-8; (vol 1).
4. Gupta AK, Bluhm R. Seborrheic dermatitis. J Eur Acad Dermatol Venereol 2004; 18: 13-26.
5. Faergemann J. Management of seborrheic dermatitis and pityriasis versicolor. Am J Clin Dermatol 2000; 1: 75-80.
6. Faergemann J, Bergbrant IM, Dohse M, Scott A, Westgate G. Seborrheic dermatitis and Pityrosporum (Malessezia) folliculitis: characterization of inflammatory cells and mediators in the skin by immunochemistry. Br J Dermatol 2001; 144: 549-56.
7. Plewig G, Jansen T. Seborrheic Dermatitis. In: Freedberg IM, Eisen AZ, Wolff K, et al., eds. Fitzpatrick's Dermatology in General Medicine, 5th ed. New York: McGraw-Hill, 1999: 1482-9; (vol 1).
8. Parsad D, Pandhi R, Negi KS, Kumar B. Topical metronidazole in seborrheic dermatitis - a double-blind study. Dermatology 2001; 202: 35-7.
9. Siadat AH, Iraji F, Shahmoradi Z, Enshaieh S, Taheri A. The efficacy of 1% metronidazole gel in facial seborrheic dermatitis: A double blind study. Indian J Dermatol Venereol Leprol 2006; 72: 266-9.
10. Danby FW, Maddin WS, Margesson U, Rosenthal D. A randomized, double-blind, placebo-controlled trial of ketoconazole 2% shampoo versus selenium sulfide 2.5% shampoo in the treatment of moderate to severe dandruff. J Am Acad Dermatol 1993; 29: 1008-12.
11. Van Cutsem J, Van Gerven F, Fransen J, Schrooten P, Janssen PA. The in vitro antifungal activity of ketoconazole, zinc pyrithione, and selenium sulfide against Pityrosporum and their efficacy as a shampoo in the treatment of experimental pityrosporosis in guinea pigs. J Am Acad Dermatol 1990; 22: 993-8.
12. Johnson BA, Nunley JR. Treatment of seborrheic dermatitis. Am Fam Physician 2000; 61: 2703-10.
13. Faergemann J. Management of seborrheic dermatitis and pityriasis versicolor. Am J Clin Dermatol 2000; 1: 75-80.
14. Squire RA, Goode K. A randomised, single-blind, single-centre clinical trial to evaluate comparative clinical efficacy of shampoos containing ciclopirox olamine (1.5%) and salicylic acid (3%), or ketoconazole (2%, Nizoral) for the treatment of dandruff/seborrhoeic dermatitis. J Dermatolog Treat 2002; 13: 51-60.
15. Unholzer A, Varigos G, Nicholls D, Schinzel S, Nietsch KH, Ulbricht H, Korting HC. Ciclopiroxolamine cream for treating seborrheic dermatitis: a double-blind parallel group comparison. Infection 2002; 30: 373-6.
16. Gunduz K, Inanir I, Sacar H. Efficacy of terbinafine 1% cream on seborrhoeic dermatitis. J Dermatol 2005; 32: 22-5.
17. Vena GA, Micali G, Santoianni P, Cassano N, Peruzzi E. Oral terbinafine in the treatment of multi-site seborrhoic dermatitis: a multicenter, double-blind placebo-controlled study. Int J Immunopathol Pharmacol 2005; 18: 745-53.
18. Baysal V, Yildirim M, Ozcanli C, Ceyhan AM. Itraconazole in the treatment of seborrheic dermatitis: a new treatment modality. Int J Dermatol 2004; 43: 63-6.
19. Kose O, Erbil H, Gur AR. Oral itraconazole for the treatment of seborrhoeic dermatitis: an open, noncomparative trial. J Eur Acad Dermatol Venereol 2005; 19: 172-5.
20. Rigopoulos D, Ioannides D, Kalogeromitros D, Gregoriou S, Katsambas A. Pimecrolimus cream 1% vs. betamethasone 17-valerate 0.1% cream in the treatment of seborrhoeic dermatitis. A randomized open-label clinical trial. Br J Dermatol 2004; 151: 1071-5.
21. Braza TJ, DiCarlo JB, Soon SL, McCall CO. Tacrolimus 0.1% ointment for seborrhoeic dermatitis: an open-label pilot study. Br J Dermatol 2003; 148: 1242-4.
22. Leite AZ, Sipahi AM, Damiao AO, et al. Protective effect of metronidazole on uncoupling oxidative phosphorylation induced by NSAID: a new mechanism. Gut 2001; 48: 163-7.
23. Jones D. Reactive oxygen species and rosacea. Cutis 2004; 74(Supp 1): 17-20.
24. Miyachi Y. Potential antioxidant mechanism of action for metronidazole: implications for rosacea management. Adv Ther 2001; 18: 237-43.